EN2602: Comprehensive Hematology and Oncology Review Course

Instructions

Saturday, November 1, 2025, 12:00 AM - Monday, November 30, 2026, 11:59 PM

AMA PRA Category 1 Credits™ (34.50 hours), Non-Physician (34.50 hours)

Overview
Join our renowned experts from Fred Hutchinson Cancer Center and the University of Washington for the 16th Annual Comprehensive Hematology and Oncology Review Course. This program includes 54 talks covering the breadth of key clinical updates across Hematology and Oncology sub-specialties along with updates on supportive care and associated specialties.

The lectures review data that inform current guidelines, recommendations, and recent advances regarding therapeutic options for patients with solid tumors and malignant and benign hematologic disorders. After completing the course, learners will have a deeper understanding of the pathogenesis, diagnostic evaluation, and therapeutic modalities available for a breadth of solid tumors and hematologic disorders.

METHOD OF PARTICIPATION
To complete this training, access to the internet is required. You will need to attest to your participation and complete an evaluation and competency measurement at the conclusion of your participation. This must be done before the accreditation period concludes on November 30, 2026.

DISCLOSURE SUMMARY

QUESTION & ANSWER SUPPLEMENT

SYLLABUS

 

1. Describe the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common malignant hematological diseases.
2. Explain the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common solid tumor malignancies.
3. Organize new therapeutic and diagnostic approaches into clinical practice as appropriate.
4. Integrate guideline-based treatments into clinical practice while personalizing care appropriately for the patient.

Accreditation: In support of improving patient care, The University of Washington School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation: The University of Washington School of Medicine designates this Enduring Material for a maximum of 34.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation of Relevant Financial Relationships

University of Washington School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of an accredited activity, including faculty, planners, reviewers or others in control of content are required to disclose all relevant financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the start of the activity.